Log in to save to my catalogue

Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition

Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2067107951

Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

The role of KRAS, when activated through canonical mutations, has been well established in cancer
1
. Here we explore a secondary means of
KRAS
activation in cancer: focal high-level amplification of the
KRAS
gene in the absence of coding mutations. These amplifications occur most commonly in esophageal, gastric and ovarian adenoc...

Alternative Titles

Full title

Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2067107951

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2067107951

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/s41591-018-0022-x

How to access this item